Antimicrobial resistance genotypes and phenotypes of Campylobacter jejuni isolated in Italy from humans, birds from wild and urban habitats, and poultry.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 12 07 2019
accepted: 27 09 2019
entrez: 12 10 2019
pubmed: 12 10 2019
medline: 13 3 2020
Statut: epublish

Résumé

Campylobacter jejuni, a common foodborne zoonotic pathogen, causes gastroenteritis worldwide and is increasingly resistant to antibiotics. We aimed to investigate the antimicrobial resistance (AMR) genotypes of C. jejuni isolated from humans, poultry and birds from wild and urban Italian habitats to identify correlations between phenotypic and genotypic AMR in the isolates. Altogether, 644 C. jejuni isolates from humans (51), poultry (526) and wild- and urban-habitat birds (67) were analysed. The resistance phenotypes of the isolates were determined using the microdilution method with EUCAST breakpoints, and AMR-associated genes and single nucleotide polymorphisms were obtained from a publicly available database. Antimicrobial susceptibility testing showed that C. jejuni isolates from poultry and humans were highly resistant to ciprofloxacin (85.55% and 76.47%, respectively), nalidixic acid (75.48% and 74.51%, respectively) and tetracycline (67.87% and 49.02%, respectively). Fewer isolates from the wild- and urban-habitat birds were resistant to tetracycline (19.40%), fluoroquinolones (13.43%), and quinolone and streptomycin (10.45%). We retrieved seven AMR genes (tet (O), cmeA, cmeB, cmeC, cmeR, blaOXA-61 and blaOXA-184) and gyrA-associated point mutations. Two major B-lactam genes called blaOXA-61 and blaOXA-184 were prevalent at 62.93% and 82.08% in the poultry and the other bird groups, respectively. Strong correlations between genotypic and phenotypic resistance were found for fluoroquinolones and tetracycline. Compared with the farmed chickens, the incidence of AMR in the C. jejuni isolates from the other bird groups was low, confirming that the food-production birds are much more exposed to antimicrobials. The improper and overuse of antibiotics in the human population and in animal husbandry has resulted in an increase in antibiotic-resistant infections, particularly fluoroquinolone resistant ones. Better understanding of the AMR mechanisms in C. jejuni is necessary to develop new strategies for improving AMR programs and provide the most appropriate therapies to human and veterinary populations.

Identifiants

pubmed: 31603950
doi: 10.1371/journal.pone.0223804
pii: PONE-D-19-19683
pmc: PMC6788699
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Nalidixic Acid 3B91HWA56M
Ciprofloxacin 5E8K9I0O4U
beta-Lactamases EC 3.5.2.6
Tetracycline F8VB5M810T

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0223804

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nucleic Acids Res. 2017 Jan 4;45(D1):D566-D573
pubmed: 27789705
Antimicrob Agents Chemother. 2017 Jun 27;61(7):
pubmed: 28438942
Foodborne Pathog Dis. 2012 May;9(5):465-72
pubmed: 22510058
Appl Environ Microbiol. 2015 Oct 30;82(2):459-66
pubmed: 26519386
Biomed Res Int. 2013;2013:340605
pubmed: 23865047
PLoS One. 2015 Jul 01;10(7):e0131534
pubmed: 26132196
Antimicrob Agents Chemother. 2005 Jun;49(6):2515-8
pubmed: 15917560
J Clin Microbiol. 2008 Oct;46(10):3404-11
pubmed: 18701662
Infect Immun. 2015 Feb;83(2):832-45
pubmed: 25486993
J Antimicrob Chemother. 2010 Apr;65(4):601-4
pubmed: 20181573
J Antimicrob Chemother. 2001 Aug;48(2):235-40
pubmed: 11481294
Future Microbiol. 2009 Mar;4(2):189-200
pubmed: 19257846
Food Microbiol. 2018 Aug;73:122-128
pubmed: 29526197
Antimicrob Agents Chemother. 2009 Aug;53(8):3357-64
pubmed: 19506058
J Bacteriol. 2005 Nov;187(21):7417-24
pubmed: 16237025
J Med Microbiol. 2007 Jun;56(Pt 6):833-837
pubmed: 17510271
PLoS Med. 2015 Dec 23;12(12):e1001940
pubmed: 26701262
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Jpn J Infect Dis. 2007 Sep;60(5):290-4
pubmed: 17881869
J Antimicrob Chemother. 2006 Dec;58(6):1154-9
pubmed: 17023497
J Clin Microbiol. 2002 Dec;40(12):4744-7
pubmed: 12454184
Antimicrob Agents Chemother. 2000 Feb;44(2):267-71
pubmed: 10639348
Bioinformatics. 2012 Apr 15;28(8):1166-7
pubmed: 22368248
Front Microbiol. 2016 Jun 13;7:887
pubmed: 27379033
Virulence. 2013 Apr 1;4(3):230-40
pubmed: 23406779
Zoonoses Public Health. 2012 Jun;59(4):241-5
pubmed: 22103704
Antimicrob Agents Chemother. 2005 Mar;49(3):1067-75
pubmed: 15728904
Open Microbiol J. 2014 Oct 31;8:130-7
pubmed: 25408778
Int J Food Microbiol. 2009 May 31;131(2-3):277-9
pubmed: 19345436
Diagn Microbiol Infect Dis. 2015 Nov;83(3):292-4
pubmed: 26320936
Microb Drug Resist. 2014 Apr;20(2):181-8
pubmed: 24320689
Clin Microbiol Rev. 2008 Jul;21(3):505-18
pubmed: 18625685
EFSA J. 2018 Feb 27;16(2):e05182
pubmed: 32625816
Front Microbiol. 2017 May 09;8:818
pubmed: 28536568
Clin Infect Dis. 2009 Apr 15;48(8):1072-8
pubmed: 19275496
Microbes Infect. 2006 Jun;8(7):1955-66
pubmed: 16716632
Vet Microbiol. 2003 Oct 30;96(3):267-76
pubmed: 14559174
Zoonoses Public Health. 2016 Nov;63(7):545-554
pubmed: 27234414
J Clin Microbiol. 2009 Aug;47(8):2616-9
pubmed: 19494082
Biomed Res Int. 2015;2015:859845
pubmed: 26543870
Epidemiol Infect. 2006 Feb;134(1):127-30
pubmed: 16409659
Emerg Infect Dis. 2003 Feb;9(2):267-70
pubmed: 12604004
PLoS One. 2015 Mar 17;10(3):e0119268
pubmed: 25781009
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
Microb Drug Resist. 2016 Jul;22(5):432-44
pubmed: 26779841
J Appl Microbiol. 2011 Feb;110(2):513-520
pubmed: 21143711
Appl Environ Microbiol. 2009 Jul;75(13):4264-72
pubmed: 19411429
Front Microbiol. 2018 May 17;9:1014
pubmed: 29867900
PLoS One. 2012;7(8):e42599
pubmed: 22880049

Auteurs

Francesca Marotta (F)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Giuliano Garofolo (G)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Lisa di Marcantonio (L)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Gabriella Di Serafino (G)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Diana Neri (D)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Romina Romantini (R)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Lorena Sacchini (L)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Alessandra Alessiani (A)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Guido Di Donato (G)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Roberta Nuvoloni (R)

Department of Veterinary Sciences, University of Pisa, Pisa, Italy.

Anna Janowicz (A)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Elisabetta Di Giannatale (E)

National Reference Laboratory for Campylobacter, Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise "G. Caporale", Teramo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH